Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma

NCT01400672 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Treatment ineffective; Extreme toxicity

Conditions

Diffuse Intrinsic Pontine Glioma

Interventions

BIOLOGICAL: Tumor Lysate Vaccine
DRUG: Imiquimod
RADIATION: Radiation therapy

Sponsor

Masonic Cancer Center, University of Minnesota